DA Davidson Lowers Herbalife (NYSE:HLF) Price Target to $7.50

Herbalife (NYSE:HLFGet Free Report) had its price objective dropped by research analysts at DA Davidson from $13.00 to $7.50 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. DA Davidson’s price target points to a potential downside of 0.66% from the stock’s current price.

HLF has been the topic of a number of other reports. Citigroup lowered their price objective on shares of Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. B. Riley lowered their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating on the stock in a research note on Thursday. Finally, StockNews.com cut shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $10.75.

View Our Latest Stock Analysis on HLF

Herbalife Stock Performance

Herbalife stock traded up $0.74 during trading hours on Thursday, reaching $7.55. 9,766,722 shares of the stock were exchanged, compared to its average volume of 2,102,438. The firm’s 50 day moving average is $7.35 and its 200 day moving average is $9.30. The stock has a market cap of $760.42 million, a P/E ratio of 9.21, a P/E/G ratio of 0.26 and a beta of 1.19. Herbalife has a 52-week low of $6.59 and a 52-week high of $15.66.

Herbalife (NYSE:HLFGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. Herbalife had a net margin of 1.63% and a negative return on equity of 18.69%. Equities research analysts expect that Herbalife will post 1.34 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Juan Miguel Mendoza bought 10,000 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The shares were acquired at an average cost of $7.11 per share, with a total value of $71,100.00. Following the completion of the transaction, the director now owns 120,000 shares of the company’s stock, valued at approximately $853,200. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC raised its holdings in Herbalife by 465.3% in the second quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock valued at $37,000 after buying an additional 2,908 shares during the period. nVerses Capital LLC raised its stake in shares of Herbalife by 240.0% during the second quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock valued at $53,000 after purchasing an additional 3,600 shares during the period. Public Employees Retirement System of Ohio raised its stake in shares of Herbalife by 22.9% during the first quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company’s stock valued at $56,000 after purchasing an additional 1,035 shares during the period. Van ECK Associates Corp raised its stake in shares of Herbalife by 10.3% during the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock valued at $90,000 after purchasing an additional 808 shares during the period. Finally, Foundry Partners LLC acquired a new stake in shares of Herbalife during the first quarter worth approximately $105,000.

Herbalife Company Profile

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Recommended Stories

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.